All Pharma News
Wyeth Pharma`s Biologic Besponsa (inotuzumab ozogamicin) Receives Approval in the U.S.

Wyeth Pharma`s Biologic Besponsa (inotuzumab ozogamicin) Receives Approval in the U.S.
FDA
06 Mar 2024
Share Share
Wyeth’s Mylotarg (Gemtuzumab Ozogamicin) Receives Supplemental Approval In US

Wyeth’s Mylotarg (Gemtuzumab Ozogamicin) Receives Supplemental Approval In US
FDA
17 Jun 2020
Share Share
FDA approves gemtuzumab ozogamicin for CD33-positive AML in pediatric patients

FDA approves gemtuzumab ozogamicin for CD33-positive AML in pediatric patients
FDA
16 Jun 2020
Share Share
Wyeth’s Mylotarg (Gemtuzumab Ozogamicin) Receives Supplemental Approval In US

Wyeth’s Mylotarg (Gemtuzumab Ozogamicin) Receives Supplemental Approval In US
FDA
29 Feb 2020
Share Share
Wyeth Pharm’s Mylotarg (Gemtuzumab Ozogamicin) Receives Supplemental Approval In US

Wyeth Pharm’s Mylotarg (Gemtuzumab Ozogamicin) Receives Supplemental Approval In US
FDA
12 Apr 2018
Share Share
Wyeth Pharm’s Inotuzumab Ozogamicin Receives Supplemental Approval In US

Wyeth Pharm’s Inotuzumab Ozogamicin Receives Supplemental Approval In US
FDA
18 Aug 2017
Share Share
Pfizer faces first 2017 patent loss as Pristiq generics crash the party

Pfizer faces first 2017 patent loss as Pristiq generics crash the party
Eric Palmer FIERCE PHARMA
11 Mar 2017
Share Share
Pfizer Resubmits US and EU Application for Withdrawn ADC Mylotarg

Pfizer Resubmits US and EU Application for Withdrawn ADC Mylotarg
Dan Stanton BIOPHARMA REPORTER
02 Feb 2017
Share Share
Is Biopharma Productivity In A Sharp Decline?

Is Biopharma Productivity In A Sharp Decline?
John LaMattina FORBES
12 Oct 2016
Share Share
West Chester agrees to settle litigation with Wyeth, Pfizer

West Chester agrees to settle litigation with Wyeth, Pfizer
DAILY LOCAL
25 May 2016
Share Share